Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study.

CONCLUSION: Serum FGF21 level was an independent predictor for new-onset MetS in a population-based prospective study.
PMID: 29436198 [PubMed - in process]

Source: Yonsei Medical Journal - February 13, 2018 Category: Universities & Medical Training Authors: Choi JR, Kim JY, Park IH, Huh JH, Kim KW, Cha SK, Park KS, Sohn JH, Park JT, Koh SB Tags: Yonsei Med J Source Type: research